The Lancet. Global health 2018 03 ; 6(3); e251. doi: 10.1016/S2214-109X(18)30038-X. Epub 2018 04 23
Publications
Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Abstract
BACKGROUND: In Niger, malaria transmission is markedly seasonal with most of the disease burden occurring in children during the rainy season.
Malaria journal 2018 Feb 27; 17(1); 98. doi: 10.1186/s12936-018-2242-4. Epub 2018 02 27
Malaria
Niger
Prevention
Seasonal malaria chemoprophylaxis
The New England journal of medicine 2018 02 08; 378(6); 577-579. doi: 10.1056/NEJMc1711583. Epub 2018 02 14
Outcome of Children With Presumptive Tuberculosis in Mbarara, Rural Uganda.
Abstract
BACKGROUND: Mortality among children with presumptive tuberculosis (TB) empiric TB treatment can be high. We describe the predictors of death among children with presumptive TB, and the relation between treatment and mortality.
The Pediatric infectious disease journal 2018 02 ; 37(2); 147-152. doi: 10.1097/INF.0000000000001727. Epub 2018 12 11
Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
Abstract
There are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rotavin-M1), and
Human vaccines & immunotherapeutics 2018 02 01; 14(2); 495-499. doi: 10.1080/21645515.2017.1403705. Epub 2017 12 21
Rotavirus
rotavirus vaccination
rotavirus vaccine
Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.
Abstract
Objective: To describe the implementation and feasibility of an innovative mass vaccination strategy - based on single-dose oral cholera vaccine - to curb a cholera epidemic in a large urban setting.
Bulletin of the World Health Organization 2018 Feb 01; 96(2); 86-93. doi: 10.2471/BLT.16.189241. Epub 2017 10 19
Inequality in outcomes for adolescents living with perinatally acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis.
Abstract
INTRODUCTION: Eighty percent of adolescents living with perinatally and behaviourally acquired HIV live in sub-Saharan Africa (SSA), a continent with marked economic inequality.
Journal of the International AIDS Society 2018 Feb ; 21 Suppl 1 doi: 10.1002/jia2.25044. Epub 2019 02 16
HIV
Sustainable Development Goals adolescent perinatally acquired sub-Saharan Africa
The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study.
Abstract
BACKGROUND: Cholera prevention and control interventions targeted to neighbors of cholera cases (case-area targeted interventions [CATIs]), including improved water, sanitation, and hygiene, oral cholera vaccine (OCV), and prophylactic
PLoS medicine 2018 02 ; 15(2); e1002509. doi: 10.1371/journal.pmed.1002509. Epub 2018 02 27
High Prevalence of or Enteroinvasive Carriage among Residents of an Internally Displaced Persons Camp in South Sudan.
Abstract
Displaced persons living in camps are at an increased risk of diarrheal diseases. Subclinical carriage of pathogens may contribute to the spread of disease, especially for microbes that require a low infectious dose.
The American journal of tropical medicine and hygiene 2018 02 ; 98(2); 595-597. doi: 10.4269/ajtmh.17-0339. Epub 2017 11 30
Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children.
Abstract
BACKGROUND: In 2010, the World Health Organization (WHO) revised the paediatric dosages of anti-tuberculosis drugs, increasing rifampicin to 15 mg/kg, isoniazid to 10 mg/kg and pyrazinamide to 35 mg/kg.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2018 02 01; 22(2); 151-157. doi: 10.5588/ijtld.17.0535. Epub 2017 12 20